A Phase 2 Randomized, Double-blind, Placebo-controlled Trial of Ambroxol as a Disease-modifying Treatment for Parkinson's Disease Dementia

被引：0
|
作者：
Pasternak, S.
Silveira, C.
Coleman, K.
Garcia, R.
Wells, J.
Borrie, M.
MacDonald, P.
Bartha, R.
Jenkins, M.
Morrow, S.
Mendonca, D.
Zou, G.
Finger, E.
Rupar, T.
Tirona, R.
Jog, M.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
106
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [31] Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson's disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study
    Payne, Thomas
    Sassani, Matilde
    Buckley, Ellen
    Moll, Sarah
    Anton, Adriana
    Appleby, Matthew
    Maru, Seema
    Taylor, Rosie
    McNeill, Alisdair
    Hoggard, N.
    Mazza, Claudia
    Wilkinson, Iain D.
    Jenkins, Thomas
    Foltynie, Thomas
    Bandmann, O.
    BMJ OPEN, 2020, 10 (08):
  • [32] A Randomized, Double-Blind, Placebo-Controlled Trial of Pridopidine in Huntington's Disease
    Kieburtz, Karl
    McGarry, Andrew
    McDermott, Michael
    Kayson, Elise
    Harrison, Madaline
    Marder, Karen
    Walker, Francis
    MOVEMENT DISORDERS, 2013, 28 (10) : 1407 - 1415
  • [33] Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study
    Asako Yoritaka
    Yasuko Kobayashi
    Tetsuo Hayashi
    Shinji Saiki
    Nobutaka Hattori
    Neurological Sciences, 2021, 42 : 4767 - 4770
  • [34] Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson's disease: a pilot study
    Yoritaka, Asako
    Kobayashi, Yasuko
    Hayashi, Tetsuo
    Saiki, Shinji
    Hattori, Nobutaka
    NEUROLOGICAL SCIENCES, 2021, 42 (11) : 4767 - 4770
  • [35] Pingchan granule for depressive symptoms in parkinson's disease: A randomized, double-blind, placebo-controlled trial
    Gu, Si-chun
    Zhou, Jie
    Ye, Qing
    Yuan, Can-xing
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2021, 19 (02): : 120 - 128
  • [36] Pingchan granule for depressive symptoms in parkinson's disease:A randomized, double-blind, placebo-controlled trial
    Si-chun Gu
    Jie Zhou
    Qing Ye
    Can-xing Yuan
    Journal of Integrative Medicine, 2021, 19 (02) : 120 - 128
  • [37] Transdermal Rotigotine in Early Stage Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Trial
    Mizuno, Yoshikuni
    Nomoto, Masahiro
    Kondo, Tomoyoshi
    Hasegawa, Kazuko
    Murata, Miho
    Takeuchi, Masahiro
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2013, 28 (10) : 1447 - 1450
  • [38] Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
    Emre, Murat
    Tsolaki, Magda
    Bonuccelli, Ubaldo
    Destee, Alain
    Tolosa, Eduardo
    Kutzelnigg, Alexandra
    Ceballos-Baumann, Andres
    Zdravkovic, Slobodan
    Bladstrom, Anna
    Jones, Roy
    LANCET NEUROLOGY, 2010, 9 (10): : 969 - 977
  • [39] Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
    Aarsland, Dag
    Ballard, Clive
    Walker, Zuzana
    Bostrom, Fredrik
    Alves, Guido
    Kossakowski, Katja
    Leroi, Iracema
    Pozo-Rodriguez, Francisco
    Minthon, Lennart
    Londos, Elisabet
    LANCET NEUROLOGY, 2009, 8 (07): : 613 - 618
  • [40] DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial - Reply
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Yaffe, K
    NEUROLOGY, 2004, 62 (06) : 1030 - 1030
12345